In contrast, reduced levels of the lncRNA GAS5 in the same cell and tissue models enhanced tumor cell proliferation and resistance to trastuzumab via modulation of the miR-21/PTEN/mTOR axis [133]. The gene discussed is GAS5; the disease is neoplasm.